How This Evidence Evolved
Chest Pain Risk Stratification
Safe early discharge from the emergency department
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Objective cardiac testing at 30 days: HEART Pathway 56.7% vs usual care 68.8% (P=0.048); no MACE in early discharges
0/1h rule-out: sensitivity 96.7% (95% CI 93.4-98.7), NPV 99.1% (98.2-99.7)
Reclassified: no reduction in 1-year MI/CV death: implementation 12% vs validation 15% (adjusted OR 1.10, 95% CI 0.75–1.61)
Length of stay 10.1 → 6.8 h; discharge 50% → 71%; 30-day MI or cardiac death 0.3% after vs 0.4% before implementation (non-inferiority not demonstrated, margin 0.5%, p=0.068); 1-year events 1.8% vs 2.7%
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
A prospective validation of the HEART score for chest pain patients at the emergency department
HEART score 0-3: 6-week MACE rate 1.7%, identifying 36.4% of patients as low-risk
The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge
Objective cardiac testing at 30 days: HEART Pathway 56.7% vs usual care 68.8% (P=0.048); no MACE in early discharges
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T
0/1h rule-out: sensitivity 96.7% (95% CI 93.4-98.7), NPV 99.1% (98.2-99.7)
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial
Reclassified: no reduction in 1-year MI/CV death: implementation 12% vs validation 15% (adjusted OR 1.10, 95% CI 0.75–1.61)
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial
Length of stay 10.1 → 6.8 h; discharge 50% → 71%; 30-day MI or cardiac death 0.3% after vs 0.4% before implementation (non-inferiority not demonstrated, margin 0.5%, p=0.068); 1-year events 1.8% vs 2.7%
Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting research evidence to practice using artificial intelligence. (RAPIDx AI)-a cluster randomized study design.
Planned 12-month composite: cardiovascular mortality, new or recurrent MI, and unplanned hospital readmission
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.